Literature DB >> 28964464

Contrast-Induced Acute Kidney Injury: Pathophysiology, Manifestations, Prevention, and Management.

Travis Scharnweber1, Lea Alhilali2, Saeed Fakhran3.   

Abstract

Contrast-induced acute kidney injury is a phenomenon that has been extensively studied throughout the years. There is a large volume of literature documenting this risk, and most radiology departments and radiologists use this information when making decisions regarding contrast administration. A review of the current information on the topic of contrast-induced acute kidney injury is necessary to ensure that the risks of intravenous contrast are properly weighed against the benefits of a contrast-enhanced computed tomography scan.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CI-AKI; Contrast nephropathy; Contrast-induced acute kidney injury

Mesh:

Substances:

Year:  2017        PMID: 28964464     DOI: 10.1016/j.mric.2017.06.012

Source DB:  PubMed          Journal:  Magn Reson Imaging Clin N Am        ISSN: 1064-9689            Impact factor:   2.266


  9 in total

1.  The effect of trimetazidine on preventing contrast-induced nephropathy after cardiac catheterization.

Authors:  Xingji Lian; Wenfei He; Huimin Zhan; Jiyan Chen; Ning Tan; Pengcheng He; Yuanhui Liu
Journal:  Int Urol Nephrol       Date:  2019-10-22       Impact factor: 2.370

2.  Astaxanthin attenuates contrast-induced acute kidney injury in rats via ROS/NLRP3 inflammasome.

Authors:  Liang Song; Shun Yao; Di Zheng; Yongli Xuan; Wenhua Li
Journal:  Int Urol Nephrol       Date:  2021-10-15       Impact factor: 2.370

3.  MicroRNA-188 aggravates contrast-induced apoptosis by targeting SRSF7 in novel isotonic contrast-induced acute kidney injury rat models and renal tubular epithelial cells.

Authors:  Bowen Liu; Yunfei Chai; Wei Guo; Kaiyan Lin; Shiqun Chen; Jin Liu; Guoli Sun; Guangzhong Chen; Feier Song; Yibo He; Yan Liang; Zhaodong Guo; Li Lei; Lihao He; Liwei Liu; Ning Tan; Yong Liu; Shilong Zhong; Jiyan Chen
Journal:  Ann Transl Med       Date:  2019-08

Review 4.  Contrast-associated acute kidney injury: does it really exist, and if so, what to do about it?

Authors:  Wim Vandenberghe; Eric Hoste
Journal:  F1000Res       Date:  2019-05-29

5.  Incidence and risk of dialysis therapy within 30 days after contrast enhanced computed tomography in patients coded with chronic kidney disease: a nation-wide, population-based study.

Authors:  Yun-Ju Shih; Yu-Ting Kuo; Chung-Han Ho; Chia-Chun Wu; Ching-Chung Ko
Journal:  PeerJ       Date:  2019-09-30       Impact factor: 2.984

Review 6.  NLRP3 Inflammasome: A Promising Therapeutic Target for Drug-Induced Toxicity.

Authors:  Shanshan Wei; Wanjun Ma; Bikui Zhang; Wenqun Li
Journal:  Front Cell Dev Biol       Date:  2021-04-12

7.  A Novel Antioxidant Protects Against Contrast Medium-Induced Acute Kidney Injury in Rats.

Authors:  Shuo Huang; Yanyan Tang; Tianjun Liu; Ning Zhang; Xueyan Yang; Dingwei Yang; Ge Hong
Journal:  Front Pharmacol       Date:  2020-11-27       Impact factor: 5.810

8.  Evaluation of Crocin Effect on Contrast-Induced Nephropathy Following Coronary Angiography or Angioplasty: A Randomized Controlled Trial.

Authors:  Lida Shojaei; Shima Esfandiary; Mohammad Rouzbahani; Fatemeh Heydarpour; Mostafa Bahremand; Reza Heidary Moghadam; Ghazal Mahmoudi; Farzaneh Korani; Farshid Raissi; Foroud Shahbazi
Journal:  Iran J Pharm Res       Date:  2022-06-14       Impact factor: 1.962

9.  Wnt4 is significantly upregulated during the early phases of cisplatin-induced acute kidney injury.

Authors:  Yi-Xin He; Tian-Tian Diao; Shu-Min Song; Cen-Cen Wang; Yu Wang; Chun-Lan Zhou; Yi-Bing Bai; Shan-Shen Yu; Xuan Mi; Xin-Yu Yang; Qiu-Ju Wei; Bing Li
Journal:  Sci Rep       Date:  2018-07-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.